Acetoacetyl-CoA synthetase is essential for normal neuronal development

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 398-403

  Hasegawa, Shinya ^a   Kume, Hiroki ^a   Iinuma, Sayuri ^a   Yamasaki, Masahiro ^a   Takahashi, Noriko ^a   Fukui, Tetsuya ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Acetoacetyl CoA synthetase; Ketone body; Neuronal development; SREBP 2

Indexed keywords

ACETOACETATE COENZYME A LIGASE; CHOLESTEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHOLESTEROL SYNTHESIS; DOWN REGULATION; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURITE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; CELL LINE; COENZYME A LIGASES; GENE KNOCKDOWN TECHNIQUES; KETONE BODIES; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEURITES; NEUROGENESIS; NUCLEAR PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

EID: 84867851950     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.076     Document Type: Article

References (31)

1. Dietschy J.M., Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 2001, 12:105-112.
2. Herrera E., Amusquivar E. Lipid metabolism in the fetus and the newborn. Diabetes Metab. Res. Rev. 2000, 16:202-210.
3. Fukata Y., Fukata M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat. Rev. Neurosci. 2010, 11:161-175.
4. Mashima T., Seimiya H., Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer 2009, 100:1369-1372.
5. Bauer D.E., Hatzivassiliou G., Zhao F., Andreadis C., Thompson C.B. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 2005, 24:6314-6322.
6. Middleton B. The kinetic mechanism and properties of the cytoplasmic acetoacetyl-coenzyme A thiolase from rat liver. Biochem. J. 1974, 139:109-121.
7. Mitchell G.A., Kassovska-Bratinova S., Boukaftane Y., Robert M.F., Wang S.P., Ashmarina L., Lambert M., Lapierre P., Potier E. Medical aspects of ketone body metabolism. Clin. Invest. Med. 1995, 18:193-216.
8. MacDonald M.J., Smith A.D., Hasan N.M., Sabat G., Fahien L.A. Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell. J. Biol. Chem. 2007, 282:30596-30606.
9. Cotter D.G., d'Avignon D.A., Wentz A.E., Weber M.L., Crawford P.A. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. J. Biol. Chem. 2011, 286:6902-6910.
10. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 1999, 15:412-426.
11. Endemann G., Goetz P.G., Edmond J., Brunengraber H. Lipogenesis from ketone bodies in the isolated perfused rat liver. Evidence for the cytosolic activation of acetoacetate. J. Biol. Chem. 1982, 257:3434-3440.
12. Fukui T., Ito M., Tomita K. Purification and characterization of acetoacetyl-CoA synthetase from Zoogloea ramigera I-16-M. Eur. J. Biochem. 1982, 127:423-428.
13. Ito M., Fukui T., Kamokari M., Saito T., Tomita K. Purification and characterization of acetoacetyl-CoA synthetase from rat liver. Biochim. Biophys. Acta 1984, 794:183-193.
14. Nakamoto M., Takahashi N., Iwahori A., Sato H., Fukui T. Effects of development on acetoacetyl-CoA synthetase biosynthesis in rat liver. Biol. Pharm. Bull. 1999, 22:981-983.
15. Iwahori A., Takahashi N., Nakamoto M., Iwama M., Fukui T. CDNA-derived amino acid sequence of acetoacetyl-CoA synthetase from rat liver. FEBS Lett. 2000, 466:239-243.
16. Sato H., Takahashi N., Nakamoto M., Ohgami M., Yamazaki M., Fukui T. Effects of streptozotocin-induced diabetes on acetoacetyl-CoA synthetase activity in rats. Biochem. Pharmacol. 2002, 63:1851-1855.
17. Ohgami M., Takahashi N., Yamasaki M., Fukui T. Expression of acetoacetyl-CoA synthetase, a novel cytosolic ketone body-utilizing enzyme, in human brain. Biochem. Pharmacol. 2003, 65:989-994.
18. Ohnuki M., Takahashi N., Yamasaki M., Fukui T. Different localization in rat brain of the novel cytosolic ketone body-utilizing enzyme, acetoacetyl-CoA synthetase, as compared to succinyl-CoA:3-oxoacid CoA-transferase. Biochim. Biophys. Acta 2005, 1729:147-153.
19. S. Hasegawa, K. Noda, A. Maeda, M. Matsuoka, M. Yamasaki and T. Fukui, Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels, Mol. Genet. Metab. (2012),. http://dx.doi.org/10.1016/j.ymgme.2012.08.017.
20. Hasegawa S., Yamasaki M., Inage T., Takahashi N., Fukui T. Transcriptional regulation of ketone body-utilizing enzyme, acetoacetyl-CoA synthetase, by C/EBPalpha during adipocyte differentiation. Biochim. Biophys. Acta 2008, 1779:414-419.
21. Zheng S., Eacker S.M., Hong S.J., Gronostajski R.M., Dawson T.M., Dawson V.L. NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice. J. Clin. Invest. 2010, 120:2446-2456.
22. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 2002, 19:43-55.
23. Seeds A.E., Leung L.S., Stys S.J., Clark K.E., Russell P.T. Comparison of human and sheep chorion laeve permeability to glucose, beta-hydroxybutyrate, and glycerol. Am. J. Obstet. Gynecol. 1980, 138:604-608.
24. Alonso de la Torre S.R., Serrano M.A., Medina J.M. Carrier-mediated beta-D-hydroxybutyrate transport in brush-border membrane vesicles from rat placenta. Pediatr. Res. 1992, 32:317-323.
25. Funfschilling U., Jockusch W.J., Sivakumar N., Mobius W., Corthals K., Li S., Quintes S., Kim Y., Schaap I.A., Rhee J.S., Nave K.A., Saher G. Critical time window of neuronal cholesterol synthesis during neurite outgrowth. J. Neurosci. 2012, 32:7632-7645.
26. Suzuki S., Kiyosue K., Hazama S., Ogura A., Kashihara M., Hara T., Koshimizu H., Kojima M. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J. Neurosci. 2007, 27:6417-6427.
27. Suzuki R., Lee K., Jing E., Biddinger S.B., McDonald J.G., Montine T.J., Craft S., Kahn C.R. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 2010, 12:567-579.
28. Koper J.W., Lopes-Cardozo M., Van Golde L.M. Preferential utilization of ketone bodies for the synthesis of myelin cholesterol in vivo. Biochim. Biophys. Acta 1981, 666:411-417.
29. Chen C., Wirth A., Ponimaskin E. Cdc42: an important regulator of neuronal morphology. Int. J. Biochem. Cell Biol. 2012, 44:447-451.
30. Dent E.W., Gupton S.L., Gertler F.B. The growth cone cytoskeleton in axon outgrowth and guidance. Cold Spring Harb. Perspect. Biol. 2011, 3.
31. Deller T., Korte M., Chabanis S., Drakew A., Schwegler H., Stefani G.G., Zuniga A., Schwarz K., Bonhoeffer T., Zeller R., Frotscher M., Mundel P. Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity. Proc. Natl. Acad. Sci. USA 2003, 100:10494-10499.